Strategic leader with extensive international experience, gained in a number of senior roles. Prior to joining CS Pharmaceuticals, he was SVP Commercial at Circassia Pharmaceuticals, responsible for the Ex US business and in particular the expansion of the business in China resulting in significant sales growth and reimbursement in a number of provinces for the lead product. Prior to joining Circassia he spent 10 years at Takeda Pharmaceuticals where he was Head of Commercial Operations, Asia Pacific.
September 25, 2021
CS Pharmaceuticals Ltd (“CSP” or “the Company”), a specialty pharmaceutical company focussed on the in-license of China rights of innovative products and the development and commercialisation of them…